SHR - 1209 Treatment Efficacy and Safety of the Patients With Hypercholesterolemia Ⅲ Period Clinical Research

Comparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyperlipidemia

NCT00810979 ·Status: COMPLETED ·Phase: PHASE2

A Research Study Investigating How NNC0385-0434 is Tolerated in People With or Without High Cholesterol Levels

NCT04058834 ·Status: COMPLETED ·Phase: PHASE1

A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese Men

NCT05003440 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060304 in Healthy and Elevated LDL-C Subjects

NCT06485245 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

the Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects in Adult Subjects With Elevated LDL-C

NCT06132360 ·Status: COMPLETED ·Phase: PHASE1

Lipid Efficacy/Tolerability Study (0524A-020)

NCT00269204 ·Status: COMPLETED ·Phase: PHASE3

A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia

NCT07229937 ·Status: RECRUITING ·Phase: PHASE2

A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia

NCT02087917 ·Status: COMPLETED ·Phase: PHASE2

A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease

NCT04992065 ·Status: COMPLETED ·Phase: PHASE2

Phase 1 to Evaluate the Safety and Pharmacokinetic Characteristics of Fixed-dose Combination of YYC506

NCT04874129 ·Status: UNKNOWN ·Phase: PHASE1

Effect of Alirocumab on Postprandial Hyperlipemia in Patients With Type 2 Diabetes

NCT03344692 ·Status: COMPLETED ·Phase: PHASE3

Safety Study of BMS-844421 for Treatment of Hypercholesterolemia

NCT01082562 ·Status: TERMINATED ·Phase: PHASE1

A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol

NCT01426412 ·Status: COMPLETED ·Phase: PHASE1

The Effects of Coenzyme A Combined With Statin on Serum Lipids in Patients With Hyperlipidemia

NCT01928342 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis

NCT01250990 ·Status: COMPLETED ·Phase: NA

Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060380 in Healthy and Elevated LDL-C Subjects

NCT06573528 ·Status: COMPLETED ·Phase: PHASE1

An Experimental Medicine Study to Evaluate Serum Biomarkers of Lipid Metabolism

NCT00847782 ·Status: COMPLETED ·Phase: NA

Adult Subjects With Elevated Low-Density Lipoprotein-Cholesterol to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects

NCT05905068 ·Status: COMPLETED ·Phase: PHASE1

K-924 Phase III Long Term Study

NCT04289662 ·Status: COMPLETED ·Phase: PHASE3

Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A

NCT04874142 ·Status: COMPLETED ·Phase: PHASE1

Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care

NCT00345657 ·Status: COMPLETED ·Phase: PHASE4

Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506.

NCT04858308 ·Status: UNKNOWN ·Phase: PHASE3

Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects

NCT02676596 ·Status: COMPLETED ·Phase: PHASE1

Comparison of Coenzyme A and Pantethine Capsule for Safety and Efficacy On Patients With Hyperlipidemia

NCT01811082 ·Status: COMPLETED ·Phase: PHASE3

A Long-term Study of ERN/LRPT (Extended Release Niacin/Laropiprant [MK0524A]) in Patients With Dyslipidemia (0524A-102)

NCT00961636 ·Status: COMPLETED ·Phase: PHASE3